Вздутие живота: анализ происхождения симптома
https://doi.org/10.26295/OS.2020.80.96.002
Аннотация
Ключевые слова
Список литературы
1. Chami T. N., Schuster M. M., Bohlman M. E., Pulliam T. J., Kamal N., Whitehead W. E. A simple radiologic method to estimate the quantity of bowel gas // Am J Gastroenterol. 1991; 86: 599–602.
2. Azpiroz F. Intestinal gas dynamics: mechanisms and clinical relevance // Gut. 2005; 54 (7): 893–895. DOI: 10.1136/gut.2004.048868.
3. Iovino P., Bucci C., Tremolaterra F., Santonicola A., Chiarioni G. Bloating and functional gastrointestinal disorders: where are we and where are we going? // World J Gastroenterol. 2014; 20 (39): 14407–14419. DOI: 10.3748/wjg.v20.i39.14407.
4. Sarna S. K. Colonic Motility: From Bench Side to Bedside. San Rafael (CA): Morgan & Claypool Life Sciences, 2010.
5. Auwerda J. J., Bac D. J., Schouten W. R. Circadian rhythm of rectal motor complexes // Dis Colon Rectum. 2001; 44: 1328–1332. DOI: 10.1007/ BF02234793.
6. Accarino A. M., Azpiroz F., Malagelada J. R. Attention and distraction: effects on gut perception // Gastroenterology. 1997; 113: 415–422.
7. Accarino A. M., Azpiroz F., Malagelada J. R. Effect of selective CCK1 receptor antagonism on accommodation and tolerance of intestinal gas in functional gut disorders // J Gastroenterol Hepatol. 2016; 31 (2): 288–293. DOI: 10.1111/jgh.13177.
8. Nguyen H. N., Winograd R., Domingues G. R., Lammert F. Postprandial transduodenal bolus transport is regulated by complex peristaltic sequence // World J Gastroenterol. 2006; 12 (37): 6008–6016. DOI: 10.3748/wjg.v12.i37.6008.
9. Castedal M., Björnsson E., Abrahamsson H. Postprandial peristalsis in the human duodenum // Neurogastroenterol Motil. 1998; 10 (3): 227–233. DOI: 10.1046/j.1365-2982.1998.00098.x.
10. Kellow J. E., Eckersley C. M., Jones M. P. Enhanced perception of physiological intestinal motility in the irritable bowel syndrome // Gastroenterology. 1991; 101: 1621–1627.
11. Koide A., Yamaguchi T., Odaka T., et al. Quantitative analysis of bowel gas using plain abdominal radiograph in patients with irritable bowel syndrome // Am J Gastroenterol. 2000; 95: 1735–1741.
12. Lewis M. J., Reilly B., Houghton L. A., Whorwell P. J. Ambulatory abdominal inductance plethysmography: towards objective assessment of abdominal distension in irritable bowel syndrome // Gut. 2001; 48 (2): 216–220. DOI: 10.1136/ gut.48.2.216.
13. Seo A. Y., Kim N., Oh D. H. Abdominal bloating: pathophysiology and treatment // J Neurogastroenterol Motil. 2013; 19 (4): 433–453. DOI: 10.5056/jnm.2013.19.4.433.
14. Salvioli B., Serra J., Azpiroz F., et al. Origin of gas retention and symptoms in patients with bloating // Gastroenterology. 2005; 128: 574–579. 15. Mearin F., Lacy B. E., Chang L., Chey W. D., Lembo A. J., Simren M., Spiller R. Bowel Disorders // Gastroenterology. 2016. Pii: S0016-5085(16)00222-5. DOI: 10.1053/j.gastro.2016.02.031.
15. Agrawal A., Houghton L. A., Reilly B., Morris J., Whorwell P. J. Bloating and distension in irritable bowel syndrome: the role of gastrointestinal transit // Am J Gastroenterol. 2009; 104: 1998–2004.
16. Agrawal A., Houghton L. A., Lea R., Morris J., Reilly B., Whorwell P. J. Bloating and distention in irritable bowel syndrome: the role of visceral sensation // Gastroenterology. 2008; 134: 1882–1889.
17. Lilli N. L., Quénéhervé L., Haddara S., Brochard C., Aubert P., Rolli-Derkinderen M., Durand T., Naveilhan P., Hardouin J. B., de Giorgio R., Barbara G., Bruley des Varannes S., Coron E., Neunlist M. Glioplasticity in irritable bowel syndrome // Neurogastroenterol Motil. 2018; 30 (4): e13232. DOI: 10.1111/nmo.13232.
18. Accarino A. M., Azpiroz F., Malagelada J. R. Attention and distraction: effects on gut perception // Gastroenterology. 1997; 113: 415–422.
19. Song J. Y., Merskey H., Sullivan S., Noh S. Anxiety and depression in patients with abdominal bloating // Can J Psychiatry. 1993; 38: 475–479.
20. Serra J., Azpiroz F., Malagelada J. R. Impaired transit and tolerance of intestinal gas in the irritable bowel syndrome // Gut. 2001; 48: 14–19.
21. Hernando-Harder A. C., Serra J., Azpiroz F., Malagelada J. R. Sites of symptomatic gas retention during intestinal lipid perfusion in healthy subjects // Gut. 2004; 53 (5): 661–665. DOI: 10.1136/gut.2003.026385.
22. Francis C. Y., Whorwell P. J. Bran and irritable bowel syndrome: time for reappraisal // Lancet. 1994; 344: 39-40.
23. Kellow J. E., Gill R. C., Wingate D. L. Modulation of human upper gastrointestinal motility by rectal distension // Gut. 1987; 28 (7): 864–868. DOI: 10.1136/gut.28.7.864.
24. Houghton L. A., Lea R., Agrawal A., Reilly B., Whorwell P. J. Relationship of Abdominal Bloating to Distention in Irritable Bowel Syndrome and Effect of Bowel Habit // Gastroenterology. 2006; 131 (4): 1003–1010. DOI: 10.1053/j.gastro.2006.07.015.
25. Tremolaterra F., Villoria A., Azpiroz F., Serra J., Aguadé S., Malagelada J. R. Impaired viscerosomatic reflexes and abdominalwall dystony associated with bloating // Gastroenterology. 2006; 130: 1062–1068.
26. Villoria A., Azpiroz F., Burri E., Cisternas D., Soldevilla A., Malagelada J. R. Abdomino-phrenic dyssynergia in patients with abdominal bloating and distension // Am J Gastroenterol. 2011; 106: 815–819.
27. Villoria A., Azpiroz F., Soldevilla A., Perez F., Malagelada J. R. Abdominal accommodation: a coordinated adaptation of the abdominal wall to its content // Am J Gastroenterol. 2008; 103: 2807–2815.
28. Dapoigny M., Stockbrügger R. W., Azpiroz F., et al. Role of alimentation in irritable bowel syndrome // Digestion. 2003; 67: 225-233.
29. Timmermans L., Klitsie P. J., Maat A. P., de Goede B., Kleinrensink G. J., Lange J. F. Abdominal wall bulging after thoracic surgery, an underdiagnosed wound complication // Hernia. 2013; 17 (1): 89–94. DOI: 10.1007/s10029-012-0971-9.
30. Lara F. J. P., Carmona J. H., Quesada J. Q., et al. Chronic abdominal pain secondary to thoracic disc hernia: a cross-sectional study of 46 patients // Research. 2014; 1: 866. DOI: 10.13070/rs.en.1.866.
31. Chernev I., Dado D. Segmental zoster abdominal paresis (zoster pseudohernia): a review of the literature // PM&R. 2013; 5 (9): 786–90. DOI: 10.1016/j.pmrj.2013.05.013.
32. Lara F. J. P., Carmona J. H., Quesada J. Q., et al. Chronic abdominal pain secondary to thoracic disc hernia: a cross-sectional study of 46 patients // Research. 2014; 1: 866. DOI: 10.13070/rs.en.1.866.
33. Kassinen A., Krogius-Kurikka L., Mäkivuokko H., et al. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects // Gastroenterology. 2007; 133: 24–33.
34. Ponnusamy K., Choi J. N., Kim J., Lee S. Y., Lee C. H. Microbial community and metabolomic comparison of irritable bowel syndrome faeces // J Med Microbiol. 2011; 60 (6): 817–827.
35. Tana C., Umesaki Y., Imaoka A., Handa T., Kanazawa M., Fukudo S. Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome // Neurogastroenterol Motil. 2010; 22: 512–519.
36. Vernia P., Camillo M. D., Marinaro V., Caprilli R. Effect of predominant methanogenic flora on the outcome of lactose breath test in irritable bowel syndrome patients // Eur J Clin Nutr. 2003; 57: 1116–1119.
37. Sachdev A. H., Pimentel M. Gastrointestinal bacterial overgrowth: pathogenesis and clinical significance // Ther Adv Chronic Dis. 2013; 4 (5): 223–231. DOI: 10.1177/2040622313496126.
38. Kim S. E., Choi S. C., Park K. S., et al. Change of fecal flora and effectiveness of the short-term VSL#3 probiotic treatment in patients with functional constipation // J Neurogastroenterol Motil. 2015; 21: 111–120. DOI: 10.5056/jnm14048.
39. Bajaj J. S., Barbara G., DuPont H. L., Mearin F., Gasbarrini A., Tack J. New concepts on intestinal microbiota and the role of the non-absorbable antibiotics with special reference to rifaximin in digestive diseases // Dig Liver Dis. 2018; 50 (8): 741–749. DOI: 10.1016/j.dld.2018.04.020.
40. Li J., Zhu W., Liu W., Wu Y., Wu B. Rifaximin for Irritable Bowel Syndrome: A Meta-Analysis of Randomized Placebo-Controlled Trials // Medicine (Baltimore). 2016; 95 (4): e2534. DOI: 10.1097/MD.0000000000002534. PMID: 26825893; PMCID: PMC5291563.
41. Ringel-Kulka T., Palsson O. S., Maier D., Carroll I., Galanko J. A., Leyer G., Ringel Y. Probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 versus placebo for the symptoms of bloating in patients with functional bowel disorders: a double-blind study // J Clin Gastroenterol. 2011; 45 (6): 518–525. DOI: 10.1097/MCG.0b013e31820ca4d6. PMID: 21436726; PMCID: PMC4372813.
42. El-Salhy M., Ystad S. O., Mazzawi T., Gundersen D. Dietary fiber in irritable bowel syndrome (Review) // Int J Mol Med. 2017; 40 (3): 607–613. DOI: 10.3892/ijmm.2017.3072.
43. Zhang Z., Tang H., Chen P., Xie H., Tao Y. Demystifying the manipulation of host immunity, metabolism, and extraintestinal tumors by the gut microbiome // Signal Transduction and Targeted Therapy. 2019; 4: Article number: 41.
44. Roberfroid M., Gibson G. R., Hoyles L., McCartney A. L., Rastall R., Rowland I., Wolvers D., Watzl B., Szajewska H., Stahl B., et al. Prebiotic effects: Metabolic and health benefits // Br J Nutr. 2010; 104 (2): S1–S63. DOI: 10.1017/S0007114510003363.
45. Holzer P., Farzi A. Neuropeptides and the microbiota-gut-brain axis // Adv Exp Med Biol. 2014; 817: 195–219. DOI: 10.1007/978-1-4939-0897-4_9.
46. Soret R., Chevalier J., de Coppet P., Poupeau G., Derkinderen P., Segain J. P., Neunlist M. Shortchain fatty acids regulate the enteric neurons and control gastrointestinal motility in rats // Gastroenterology. 2010; 138: 1772–1782. DOI: 10.1053/j.gastro.2010.01.053.
Рецензия
Для цитирования:
Шульпековa Ю.О. Вздутие живота: анализ происхождения симптома. Лечащий Врач. 2020;(8):16-25. https://doi.org/10.26295/OS.2020.80.96.002
For citation:
Shulpekova Yu.O. Bloating: analysis of the origin of the symptom. Lechaschi Vrach. 2020;(8):16-25. (In Russ.) https://doi.org/10.26295/OS.2020.80.96.002
Просмотров: 169
Послать статью по эл. почте 
